Single-dose Mass Balance Recovery and Metabolite Profile and Identification of 14C-XEN1101
Clinical trial NCT04952467 · COMPLETED
Trial details
- NCT number
- NCT04952467
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2021-10-04
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.